Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Pulmonx Corp (NQ: LUNG )

6.300 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Nov 27, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Pulmonx Corp

< Previous 1 2 Next >
Pulmonx to Present at the Piper Sandler 36th Annual Healthcare Conference
From Pulmonx Corporation
Via GlobeNewswire
Pulmonx Partners with American Lung Association to Launch New Educational Initiatives for COPD Patients and Providers
From Pulmonx Corporation
Via Business Wire
Pulmonx to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
From Pulmonx Corporation
Via GlobeNewswire
Pulmonx to Present at the Stifel 2024 Healthcare Conference
From Pulmonx Corporation
Via GlobeNewswire
Pulmonx Reports Third Quarter 2024 Financial Results
From Pulmonx Corporation
Via GlobeNewswire
Pulmonx to Report Third Quarter 2024 Financial Results on October 30, 2024
From Pulmonx Corporation
Via GlobeNewswire
Pulmonx Announces Presentation of Clinical Data from the AeriSeal® CONVERT Trial and 5-Year Follow-up Data from the LIBERATE Study at the European Respiratory Society Congress 2024
From Pulmonx Corporation
Via GlobeNewswire
Pulmonx to Participate in the Lake Street 8th Annual Best Ideas Growth Conference
From Pulmonx Corporation
Via GlobeNewswire
Pulmonx to Present at the 2024 Wells Fargo Healthcare Conference
From Pulmonx Corporation
Via GlobeNewswire
Pulmonx Reports Second Quarter 2024 Financial Results
From Pulmonx Corporation
Via GlobeNewswire
Pulmonx to Present at the Canaccord Genuity 44th Annual Growth Conference
From Pulmonx Corporation
Via GlobeNewswire
Pulmonx to Report Second Quarter 2024 Financial Results on July 31, 2024
From Pulmonx Corporation
Via GlobeNewswire
Pulmonx Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
From Pulmonx Corporation
Via GlobeNewswire
Pulmonx Reports First Quarter 2024 Financial Results
Achieves 30% year-over-year worldwide revenue growth 
From Pulmonx Corporation
Via GlobeNewswire
Pulmonx to Report First Quarter 2024 Financial Results on May 1, 2024
From Pulmonx Corporation
Via GlobeNewswire
Pulmonx Announces Appointment of Mehul Joshi as Chief Financial Officer
From Pulmonx Corporation
Via GlobeNewswire
Pulmonx Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
From Pulmonx Corporation
Via GlobeNewswire
Pulmonx Announces Treatment of the First Patient with the AeriSeal® System in CONVERT II Pivotal Trial
From Pulmonx Corporation
Via Business Wire
Pulmonx Reports Fourth Quarter and Full Year 2023 Financial Results
From Pulmonx Corporation
Via GlobeNewswire
Pulmonx Announces Retirement of CEO Glen French and Appointment of Industry Veteran Steve Williamson as President and Chief Executive Officer
From Pulmonx Corporation
Via GlobeNewswire
Pulmonx to Report Fourth Quarter and Full Year 2023 Financial Results on February 21, 2024
From Pulmonx Corporation
Via GlobeNewswire
The Honest Company Announces Appointment of Michael Barkley, Alissa Hsu Lynch, and Andrea Turner to the Board of Directors
From The Honest Company, Inc.
Via GlobeNewswire
Pulmonx to Present at the Piper Sandler 35th Annual Healthcare Conference
From Pulmonx Corporation
Via GlobeNewswire
Pulmonx to Participate at Upcoming Investor Conferences
From Pulmonx Corporation
Via GlobeNewswire
Pulmonx Reports Record Third Quarter 2023 Financial Results
From Pulmonx Corporation
Via GlobeNewswire
Pulmonx to Report Third Quarter 2023 Financial Results on October 30, 2023
From Pulmonx Corporation
Via GlobeNewswire
Pulmonx Announces CFO Transition and Record Preliminary Third Quarter 2023 Revenue
From Pulmonx Corporation
Via GlobeNewswire
Pulmonx to Participate at Upcoming Investor Conferences
From Pulmonx Corporation
Via GlobeNewswire
Pulmonx Reports Second Quarter 2023 Financial Results
From Pulmonx Corporation
Via GlobeNewswire
Pulmonx to Present at the Canaccord Genuity 43rd Annual Growth Conference
From Pulmonx Corporation
Via GlobeNewswire
< Previous 1 2 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.